Search

everythinglearnresearchcommunity

for

Search:↓

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Treating stubborn hair loss involves both medical and emotional support options.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

More precise, personalized therapies are needed for autoimmune diseases.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Vaccination is the most effective way to reduce COVID-19 transmission.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

FLCN helps control iron levels in cells.